Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Motor Activity 13 Colonic Neoplasms 9 Colorectal Neoplasms 8 Neoplasms 7 Rectal Neoplasms 6 Breast Neoplasms 6 Stomach Neoplasms 5 Lung Neoplasms 4 Esophageal Neoplasms 4 Smoking Cessation 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Frailty 3 Urinary Bladder Neoplasms 2 Postoperative Complications 2 Insulin Resistance 2 Disease 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Urologic Neoplasms 1 Smoking 1 Sarcopenia 1 Risk Reduction Behavior 1 Patient Preference 1 Pancreatitis, Chronic 1 Pain 1 Obesity 1 Nutrition Disorders 1

Interventions

Megestrol Acetate 9 Exercise 6 Standard of Care 4 Blood Specimen Collection 4 Olanzapine 3 Ibuprofen 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Infliximab 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 alkaloid GB18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Preoperative Exercise × Clear all

NCT03770117 2021-01-19

SIPUP

Manchester University NHS Foundation Trust

Cachexia, Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡